China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA: 600062)

China Resources Double-Crane Pharmaceutical Co.,Ltd. Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2,706	3,457	2,630	2,834	2,410	1,844
Short-Term Investments	-	-	-	-	-	100.06
Trading Asset Securities	-	-	200.49	803.58	851.95	758.14
Cash & Short-Term Investments	2,706	3,457	2,831	3,638	3,262	2,702
Cash Growth	-19.53%	22.12%	-22.18%	11.51%	20.73%	28.31%
Accounts Receivable	2,656	2,349	2,211	1,978	2,086	2,004
Other Receivables	69.45	54.48	468.98	66.14	50.5	50.49
Receivables	2,725	2,403	2,680	2,044	2,137	2,054
Inventory	1,538	1,562	1,900	1,665	1,289	1,146
Prepaid Expenses	-	0.01	-	0.59	-	-
Other Current Assets	313.92	215.79	227.89	174.55	112.22	136.17
Total Current Assets	7,283	7,638	7,639	7,523	6,800	6,039
Property, Plant & Equipment	4,153	3,810	3,571	2,957	2,673	2,622
Long-Term Investments	1,102	356.63	350.29	303.43	370.08	34.27
Goodwill	907.9	906.06	934.96	788.19	796.41	839.83
Other Intangible Assets	1,973	1,691	1,648	1,193	1,094	1,074
Long-Term Deferred Tax Assets	129.36	126.49	127.19	73.77	52.22	50.3
Long-Term Deferred Charges	767.24	813	792.3	723.66	569.38	574.94
Other Long-Term Assets	228.55	88.75	103.27	114.6	60.72	43.08
Total Assets	16,545	15,431	15,165	13,676	12,416	11,277
Accounts Payable	722.74	722.51	750.39	847.4	848.05	690.76
Accrued Expenses	426.87	1,329	1,496	1,283	1,149	1,038
Short-Term Debt	65.55	59.47	36.95	4.75	-	57.3
Current Portion of Long-Term Debt	20.97	200.25	0.27	-	-	7
Current Portion of Leases	-	22.49	19.46	17.84	-	-
Current Income Taxes Payable	153.88	65.7	77.78	59.62	58.92	48.19
Current Unearned Revenue	233.71	210.2	194.21	201.35	146.24	221.89
Other Current Liabilities	2,944	552.61	507.17	317.31	467.45	278.69
Total Current Liabilities	4,568	3,162	3,082	2,731	2,670	2,341
Long-Term Debt	599.91	-	200	-	-	-
Long-Term Leases	25.08	29.95	32.93	35.43	-	-
Long-Term Unearned Revenue	163.49	180.63	199.61	153.92	101.02	98
Long-Term Deferred Tax Liabilities	147.6	157.36	176.17	120.35	103.62	104.79
Other Long-Term Liabilities	5.67	1.67	5.06	1.11	14.4	14.4
Total Liabilities	5,657	3,641	3,840	3,199	3,040	2,600
Common Stock	1,039	1,040	1,043	1,043	1,043	1,043
Additional Paid-In Capital	190.39	165.19	275.22	149.39	149.39	149.39
Retained Earnings	9,042	10,011	9,415	8,718	8,102	7,414
Treasury Stock	-80.62	-125.56	-175.68	-	-	-
Comprehensive Income & Other	2.45	0.25	-1.43	-5.17	-0.28	-3.86
Total Common Equity	10,194	11,090	10,556	9,905	9,294	8,603
Minority Interest	695.01	699.36	768.46	571.06	82.88	74.05
Shareholders' Equity	10,889	11,790	11,325	10,477	9,377	8,677
Total Liabilities & Equity	16,545	15,431	15,165	13,676	12,416	11,277
Total Debt	711.52	312.16	289.61	58.02	-	64.3
Net Cash (Debt)	1,994	3,145	2,541	3,580	3,262	2,638
Net Cash Growth	-39.72%	23.75%	-29.01%	9.73%	23.67%	44.58%
Net Cash Per Share	1.94	3.07	2.45	3.43	3.13	2.53
Filing Date Shares Outstanding	1,030	1,021	1,040	1,043	1,043	1,043
Total Common Shares Outstanding	1,030	1,021	1,040	1,043	1,043	1,043
Working Capital	2,715	4,476	4,556	4,792	4,130	3,697
Book Value Per Share	9.89	10.86	10.15	9.49	8.91	8.25
Tangible Book Value	7,312	8,493	7,973	7,925	7,403	6,689
Tangible Book Value Per Share	7.10	8.32	7.67	7.60	7.10	6.41
Buildings	-	2,730	2,579	2,314	2,171	2,151
Machinery	-	3,584	3,306	2,758	2,578	2,462
Construction In Progress	-	568.24	439.72	272.81	281.03	244.22

Source: S&P Capital IQ. Standard template. Financial Sources.